{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T13:41:20Z","timestamp":1784122880573,"version":"3.55.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2018,11,5]],"date-time":"2018-11-05T00:00:00Z","timestamp":1541376000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2018,11,5]],"date-time":"2018-11-05T00:00:00Z","timestamp":1541376000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000074","name":"U.S. Department of Justice","doi-asserted-by":"publisher","award":["D-15-OD-0002"],"award-info":[{"award-number":["D-15-OD-0002"]}],"id":[{"id":"10.13039\/100000074","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["I01BX002758"],"award-info":[{"award-number":["I01BX002758"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["14S-RCS-006"],"award-info":[{"award-number":["14S-RCS-006"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["ADA12013"],"award-info":[{"award-number":["ADA12013"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["P50 DA018165"],"award-info":[{"award-number":["P50 DA018165"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1007\/s00213-018-5059-5","type":"journal-article","created":{"date-parts":[[2018,11,5]],"date-time":"2018-11-05T07:34:20Z","timestamp":1541403260000},"page":"939-952","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":57,"title":["Structure-activity relationships of bath salt components: substituted cathinones and benzofurans at biogenic amine transporters"],"prefix":"10.1007","volume":"236","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7030-557X","authenticated-orcid":false,"given":"Amy J.","family":"Eshleman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanthi","family":"Nagarajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine M.","family":"Wolfrum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John F.","family":"Reed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracy L.","family":"Swanson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron","family":"Nilsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron","family":"Janowsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,11,5]]},"reference":[{"key":"5059_CR1","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1038\/npp.2011.304","volume":"37","author":"MH Baumann","year":"2012","unstructured":"Baumann MH, Ayestas MA Jr, Partilla JS et al (2012) The designer methcathinone analogs, mephedrone and methylone, are substrates for monoamine transporters in brain tissue. Neuropsychopharmacology 37:1192\u20131203","journal-title":"Neuropsychopharmacology"},{"key":"5059_CR2","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1038\/npp.2012.204","volume":"38","author":"MH Baumann","year":"2013","unstructured":"Baumann MH, Partilla JS, Lehner KR et al (2013) Powerful cocaine-like actions of 3,4-methylenedioxypyrovalerone (MDPV), a principal constituent of psychoactive \u2018bath salts\u2019 products. Neuropsychopharmacology 38:552\u2013562","journal-title":"Neuropsychopharmacology"},{"key":"5059_CR3","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1021\/ml500113s","volume":"5","author":"BE Blough","year":"2014","unstructured":"Blough BE, Landavazo A, Partilla JS et al (2014) Hybrid dopamine uptake blocker-serotonin releaser ligands: a new twist on transporter-focused therapeutics. ACS Med Chem Lett 5:623\u2013627","journal-title":"ACS Med Chem Lett"},{"key":"5059_CR4","doi-asserted-by":"publisher","first-page":"2433","DOI":"10.1111\/bph.13030","volume":"172","author":"JS Bonano","year":"2015","unstructured":"Bonano JS, Banks ML, Kolanos R et al (2015) Quantitative structure-activity relationship analysis of the pharmacology of para-substituted methcathinone analogues. Br J Pharmacol 172:2433\u20132444","journal-title":"Br J Pharmacol"},{"key":"5059_CR5","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/s00213-013-2967-2","volume":"227","author":"K Cameron","year":"2013","unstructured":"Cameron K, Kolanos R, Vekariya R, De Felice L, Glennon RA (2013) Mephedrone and methylenedioxypyrovalerone (MDPV), major constituents of \u201cbath salts,\u201d produce opposite effects at the human dopamine transporter. Psychopharmacology 227:493\u2013499","journal-title":"Psychopharmacology"},{"key":"5059_CR6","doi-asserted-by":"publisher","first-page":"3099","DOI":"10.1016\/0006-2952(73)90196-2","volume":"22","author":"Y Cheng","year":"1973","unstructured":"Cheng Y, Prusoff WH (1973) Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. Biochem Pharmacol 22:3099\u20133108","journal-title":"Biochem Pharmacol"},{"key":"5059_CR7","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1038\/nature17629","volume":"532","author":"JA Coleman","year":"2016","unstructured":"Coleman JA, Green EM, Gouaux E (2016) X-ray structures and mechanism of the human serotonin transporter. Nature 532:334\u2013339","journal-title":"Nature"},{"key":"5059_CR8","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1016\/S0091-3057(97)00323-7","volume":"58","author":"TA Dal Cason","year":"1997","unstructured":"Dal Cason TA, Young R, Glennon RA (1997) Cathinone: an investigation of several N-alkyl and methylenedioxy-substituted analogs. Pharmacol Biochem Behav 58:1109\u20131116","journal-title":"Pharmacol Biochem Behav"},{"key":"5059_CR9","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.pnpbp.2013.08.013","volume":"48","author":"P Dawson","year":"2014","unstructured":"Dawson P, Opacka-Juffry J, Moffatt JD et al (2014) The effects of benzofury (5-APB) on the dopamine transporter and 5-HT2-dependent vasoconstriction in the rat. Prog Neuro-Psychopharmacol Biol Psychiatry 48:57\u201363","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"5059_CR10","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.lfs.2013.10.029","volume":"97","author":"LJ De Felice","year":"2014","unstructured":"De Felice LJ, Glennon RA, Negus SS (2014) Synthetic cathinones: chemical phylogeny, physiology, and neuropharmacology. Life Sci 97:20\u201326","journal-title":"Life Sci"},{"key":"5059_CR11","first-page":"65371","volume":"76","author":"Drug Enforcement Administration","year":"2011","unstructured":"Drug Enforcement Administration (2011) Schedules of controlled substances: temporary placement of three synthetic cathinones in schedule I. Final Order Fed Regist 76:65371\u201365375","journal-title":"Final Order Fed Regist"},{"key":"5059_CR12","first-page":"12171","volume":"82","author":"Drug Enforcement Administration","year":"2017","unstructured":"Drug Enforcement Administration (2017) Schedules of controlled substances: placement of 10 synthetic cathinones into schedule I. final rule. Fed Regist 82:12171\u201312177","journal-title":"Fed Regist"},{"key":"5059_CR13","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/S0022-3565(24)38214-X","volume":"289","author":"AJ Eshleman","year":"1999","unstructured":"Eshleman AJ, Carmolli M, Cumbay M et al (1999) Characteristics of drug interactions with recombinant biogenic amine transporters expressed in the same cell type. J Pharmacol Exp Ther 289:877\u2013885","journal-title":"J Pharmacol Exp Ther"},{"key":"5059_CR14","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1016\/j.bcp.2013.04.004","volume":"85","author":"AJ Eshleman","year":"2013","unstructured":"Eshleman AJ, Wolfrum KM, Hatfield MG et al (2013) Substituted methcathinones differ in transporter and receptor interactions. Biochem Pharmacol 85:1803\u20131815","journal-title":"Biochem Pharmacol"},{"key":"5059_CR15","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1124\/jpet.116.236349","volume":"360","author":"AJ Eshleman","year":"2017","unstructured":"Eshleman AJ, Wolfrum KM, Reed JF et al (2017) Structure-activity relationships of substituted cathinones, with transporter binding, uptake, and release. J Pharmacol Exp Ther 360:33\u201347","journal-title":"J Pharmacol Exp Ther"},{"key":"5059_CR16","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1021\/jm0306430","volume":"47","author":"RA Friesner","year":"2004","unstructured":"Friesner RA, Banks JL, Murphy RB et al (2004) Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. J Med Chem 47:1739\u20131749","journal-title":"J Med Chem"},{"key":"5059_CR17","doi-asserted-by":"publisher","first-page":"6177","DOI":"10.1021\/jm051256o","volume":"49","author":"RA Friesner","year":"2006","unstructured":"Friesner RA, Murphy RB, Repasky MP et al (2006) Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes. J Med Chem 49:6177\u20136196","journal-title":"J Med Chem"},{"key":"5059_CR18","doi-asserted-by":"publisher","first-page":"329","DOI":"10.2131\/jts.41.329","volume":"41","author":"T Fuwa","year":"2016","unstructured":"Fuwa T, Suzuki J, Tanaka T et al (2016) Novel psychoactive benzofurans strongly increase extracellular serotonin level in mouse corpus striatum. J Toxicol Sci 41:329\u2013337","journal-title":"J Toxicol Sci"},{"key":"5059_CR19","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1007\/s00213-014-3755-3","volume":"232","author":"MB Gatch","year":"2015","unstructured":"Gatch MB, Rutledge MA, Forster MJ (2015) Discriminative and locomotor effects of five synthetic cathinones in rats and mice. Psychopharmacology 232:1197\u20131205","journal-title":"Psychopharmacology"},{"key":"5059_CR20","doi-asserted-by":"crossref","unstructured":"Gatch MB, Forster MJ, Janowsky A, Eshleman AJ (2011) Abuse liability profile of three substituted tryptamines. J Pharmacol Exp Ther 338:280\u2013289","DOI":"10.1124\/jpet.111.179705"},{"key":"5059_CR21","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/7854_2016_41","volume":"32","author":"RA Glennon","year":"2017","unstructured":"Glennon RA, Dukat M (2017) Structure-activity relationships of synthetic cathinones. Curr Top Behav Neurosci 32:19\u201347","journal-title":"Curr Top Behav Neurosci"},{"key":"5059_CR22","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1124\/jpet.111.184119","volume":"339","author":"GC Hadlock","year":"2011","unstructured":"Hadlock GC, Webb KM, McFadden LM et al (2011) 4-Methylmethcathinone (mephedrone): neuropharmacological effects of a designer stimulant of abuse. J Pharmacol Exp Ther 339:530\u2013536","journal-title":"J Pharmacol Exp Ther"},{"key":"5059_CR23","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1021\/jm030644s","volume":"47","author":"TA Halgren","year":"2004","unstructured":"Halgren TA, Murphy RB, Friesner RA et al (2004) Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening. J Med Chem 47:1750\u20131759","journal-title":"J Med Chem"},{"key":"5059_CR24","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.annemergmed.2016.03.042","volume":"69","author":"KE Hofer","year":"2017","unstructured":"Hofer KE, Faber K, Muller DM et al (2017) Acute toxicity associated with the recreational use of the novel psychoactive benzofuran N-methyl-5-(2 aminopropyl)benzofuran. Ann Emerg Med 69:79\u201382","journal-title":"Ann Emerg Med"},{"key":"5059_CR25","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.ejphar.2012.12.006","volume":"700","author":"L Iversen","year":"2013","unstructured":"Iversen L, Gibbons S, Treble R et al (2013) Neurochemical profiles of some novel psychoactive substances. Eur J Pharmacol 700:147\u2013151","journal-title":"Eur J Pharmacol"},{"key":"5059_CR26","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1177\/0269881118754709","volume":"32","author":"LA King","year":"2018","unstructured":"King LA, Corkery JM (2018) An index of fatal toxicity for new psychoactive substances. J Psychopharmacol 32:793\u2013801","journal-title":"J Psychopharmacol"},{"key":"5059_CR27","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1021\/acschemneuro.5b00160","volume":"6","author":"R Kolanos","year":"2015","unstructured":"Kolanos R, Sakloth F, Jain AD et al (2015) Structural modification of the designer stimulant alpha-pyrrolidinovalerophenone (alpha-PVP) influences potency at dopamine transporters. ACS Chem Neurosci 6:1726\u20131731","journal-title":"ACS Chem Neurosci"},{"key":"5059_CR28","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1093\/jat\/bky022","volume":"42","author":"AJ Krotulski","year":"2018","unstructured":"Krotulski AJ, Mohr LA, Papsun DM, Logan BK (2018) Dibutylone (bk-DMBDB): intoxications, quantitative confirmations and metabolism in authentic biological specimens. J Anal Toxicol 42:437\u2013445","journal-title":"J Anal Toxicol"},{"key":"5059_CR29","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/0166-2236(91)90141-G","volume":"14","author":"MJ Kuhar","year":"1991","unstructured":"Kuhar MJ, Ritz MC, Boja JW (1991) The dopamine hypothesis of the reinforcing properties of cocaine. Trends Neurosci 14:299\u2013302","journal-title":"Trends Neurosci"},{"key":"5059_CR30","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1097\/00007691-200404000-00009","volume":"26","author":"R de la Torre","year":"2004","unstructured":"de la Torre R, Farre M, Roset PN et al (2004) Human pharmacology of MDMA: pharmacokinetics, metabolism, and disposition. Ther Drug Monit 26:137\u2013144","journal-title":"Ther Drug Monit"},{"key":"5059_CR31","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.drugalcdep.2015.04.020","volume":"152","author":"A Ledberg","year":"2015","unstructured":"Ledberg A (2015) The interest in eight new psychoactive substances before and after scheduling. Drug Alcohol Depend 152:73\u201378","journal-title":"Drug Alcohol Depend"},{"key":"5059_CR32","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1111\/j.1476-5381.2012.01998.x","volume":"167","author":"R Lopez-Arnau","year":"2012","unstructured":"Lopez-Arnau R, Martinez-Clemente J, Pubill D et al (2012) Comparative neuropharmacology of three psychostimulant cathinone derivatives: butylone, mephedrone and methylone. Br J Pharmacol 167:407\u2013420","journal-title":"Br J Pharmacol"},{"key":"5059_CR33","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.neuropharm.2017.07.026","volume":"134","author":"D Luethi","year":"2018","unstructured":"Luethi D, Kolaczynska KE, Docci L et al (2018) Pharmacological profile of mephedrone analogs and related new psychoactive substances. Neuropharmacology 134:4\u201312","journal-title":"Neuropharmacology"},{"key":"5059_CR34","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.neuropharm.2014.02.016","volume":"87","author":"JA Marusich","year":"2014","unstructured":"Marusich JA, Antonazzo KR, Wiley JL et al (2014) Pharmacology of novel synthetic stimulants structurally related to the \u201cbath salts\u201d constituent 3,4-methylenedioxypyrovalerone (MDPV). Neuropharmacology 87:206\u2013213","journal-title":"Neuropharmacology"},{"key":"5059_CR35","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1002\/dta.2053","volume":"9","author":"G McLaughlin","year":"2017","unstructured":"McLaughlin G, Morris N, Kavanagh PV et al (2017) Synthesis, characterization and monoamine transporter activity of the new psychoactive substance mexedrone and its N-methoxy positional isomer, N-methoxymephedrone. Drug Test Anal 9:358\u2013368","journal-title":"Drug Test Anal"},{"key":"5059_CR36","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1021\/jm050797a","volume":"49","author":"PC Meltzer","year":"2006","unstructured":"Meltzer PC, Butler D, Deschamps JR, Madras BK (2006) 1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (pyrovalerone) analogues: a promising class of monoamine uptake inhibitors. J Med Chem 49:1420\u20131432","journal-title":"J Med Chem"},{"key":"5059_CR37","doi-asserted-by":"publisher","first-page":"3700","DOI":"10.1021\/jm00075a027","volume":"36","author":"AP Monte","year":"1993","unstructured":"Monte AP, Marona-Lewicka D, Cozzi NV, Nichols DE (1993) Synthesis and pharmacological examination of benzofuran, indan, and tetralin analogues of 3,4-(methylenedioxy)amphetamine. J Med Chem 36:3700\u20133706","journal-title":"J Med Chem"},{"key":"5059_CR38","first-page":"81","volume":"7","author":"X Qing","year":"2014","unstructured":"Qing X, Lee XY, De Raeymaecker J, Tame J et al (2014) Pharmacophore modeling: advances, limitations, and current utility in drug discovery. J Receptor Ligand Channel Res 7:81\u201392","journal-title":"J Receptor Ligand Channel Res"},{"key":"5059_CR39","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.euroneuro.2014.12.012","volume":"25","author":"A Rickli","year":"2015","unstructured":"Rickli A, Hoener MC, Liechti ME (2015a) Monoamine transporter and receptor interaction profiles of novel psychoactive substances: para-halogenated amphetamines and pyrovalerone cathinones. Eur Neuropsychopharmacol 25:365\u2013376","journal-title":"Eur Neuropsychopharmacol"},{"key":"5059_CR40","doi-asserted-by":"publisher","first-page":"3412","DOI":"10.1111\/bph.13128","volume":"172","author":"A Rickli","year":"2015","unstructured":"Rickli A, Kopf S, Hoener MC, Liechti ME (2015b) Pharmacological profile of novel psychoactive benzofurans. Br J Pharmacol 172:3412\u20133425","journal-title":"Br J Pharmacol"},{"key":"5059_CR41","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1126\/science.2820058","volume":"237","author":"MC Ritz","year":"1987","unstructured":"Ritz MC, Lamb RJ, Goldberg SR, Kuhar MJ (1987) Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science 237:1219\u20131223","journal-title":"Science"},{"key":"5059_CR42","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1080\/15563650.2016.1271424","volume":"55","author":"L Roberts","year":"2017","unstructured":"Roberts L, Ford L, Patel N et al (2017) 11 analytically confirmed cases of mexedrone use among polydrug users. Clin Toxicol (Phila) 55:181\u2013186","journal-title":"Clin Toxicol (Phila)"},{"key":"5059_CR43","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1038\/npp.2014.325","volume":"40","author":"K Saha","year":"2015","unstructured":"Saha K, Partilla JS, Lehner KR et al (2015) \u2018Second-generation\u2019 mephedrone analogs, 4-MEC and 4-MePPP, differentially affect monoamine transporter function. Neuropsychopharmacology 40:1321\u20131331","journal-title":"Neuropsychopharmacology"},{"key":"5059_CR44","doi-asserted-by":"publisher","first-page":"2210","DOI":"10.1111\/bph.13043","volume":"172","author":"F Sakloth","year":"2015","unstructured":"Sakloth F, Kolanos R, Mosier PD et al (2015) Steric parameters, molecular modeling and hydropathic interaction analysis of the pharmacology of para-substituted methcathinone analogues. Br J Pharmacol 172:2210\u20132218","journal-title":"Br J Pharmacol"},{"key":"5059_CR45","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1006\/jmbi.1993.1626","volume":"234","author":"A Sali","year":"1993","unstructured":"Sali A, Blundell TL (1993) Comparative protein modelling by satisfaction of spatial restraints. J Mol Biol 234:779\u2013815","journal-title":"J Mol Biol"},{"key":"5059_CR46","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1124\/mol.115.101394","volume":"89","author":"W Sandtner","year":"2016","unstructured":"Sandtner W, Stockner T, Hasenhuetl PS et al (2016) Binding mode selection determines the action of ecstasy homologs at monoamine transporters. Mol Pharmacol 89:165\u2013175","journal-title":"Mol Pharmacol"},{"key":"5059_CR47","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1007\/s00213-015-4057-0","volume":"233","author":"CW Schindler","year":"2016","unstructured":"Schindler CW, Thorndike EB, Goldberg SR et al (2016) Reinforcing and neurochemical effects of the \u201cbath salts\u201d constituents 3,4-methylenedioxypyrovalerone (MDPV) and 3,4-methylenedioxy-N-methylcathinone (methylone) in male rats. Psychopharmacology 233:1981\u20131990","journal-title":"Psychopharmacology"},{"key":"5059_CR48","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.1110\/ps.062416606","volume":"15","author":"MY Shen","year":"2006","unstructured":"Shen MY, Sali A (2006) Statistical potential for assessment and prediction of protein structures. Protein Sci 15:2507\u20132524","journal-title":"Protein Sci"},{"key":"5059_CR49","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1021\/jm050540c","volume":"49","author":"W Sherman","year":"2006","unstructured":"Sherman W, Day T, Jacobson MP et al (2006) Novel procedure for modeling ligand\/receptor induced fit effects. J Med Chem 49:534\u2013553","journal-title":"J Med Chem"},{"key":"5059_CR50","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s00210-016-1297-4","volume":"390","author":"JA Shimshoni","year":"2017","unstructured":"Shimshoni JA, Winkler I, Golan E, Nutt D (2017) Neurochemical binding profiles of novel indole and benzofuran MDMA analogues. Naunyn Schmiedeberg\u2019s Arch Pharmacol 390:15\u201324","journal-title":"Naunyn Schmiedeberg\u2019s Arch Pharmacol"},{"key":"5059_CR51","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/7854_2016_20","volume":"32","author":"LD Simmler","year":"2017","unstructured":"Simmler LD, Liechti ME (2017) Interactions of cathinone NPS with human transporters and receptors in transfected cells. Curr Top Behav Neurosci 32:49\u201372","journal-title":"Curr Top Behav Neurosci"},{"key":"5059_CR52","doi-asserted-by":"publisher","unstructured":"Simmler LD, Liechti ME (2018) Pharmacology of MDMA- and amphetamine-like new psychoactive substances. In: Handbook of experimental pharmacology. Springer, Berlin. https:\/\/doi.org\/10.1007\/164_2018_113","DOI":"10.1007\/164_2018_113"},{"key":"5059_CR53","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.neuropharm.2013.11.008","volume":"79","author":"LD Simmler","year":"2014","unstructured":"Simmler LD, Rickli A, Hoener MC, Liechti ME (2014) Monoamine transporter and receptor interaction profiles of a new series of designer cathinones. Neuropharmacology 79:152\u2013160","journal-title":"Neuropharmacology"},{"key":"5059_CR54","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.forsciint.2017.08.007","volume":"279","author":"SN Staeheli","year":"2017","unstructured":"Staeheli SN, Boxler MI, Oestreich A et al (2017) Postmortem distribution and redistribution of MDAI and 2-MAPB in blood and alternative matrices. Forensic Sci Int 279:83\u201387","journal-title":"Forensic Sci Int"},{"key":"5059_CR55","doi-asserted-by":"publisher","unstructured":"Tettey JNA, Crean C, Ifeagwu SC, Raithelhuber M (2018) Emergence, diversity, and control of new psychoactive substances: a global perspective. In: Handbook of experimental pharmacology. Springer, Berlin. https:\/\/doi.org\/10.1007\/164_2018_127","DOI":"10.1007\/164_2018_127"},{"key":"5059_CR56","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1097\/FTD.0000000000000263","volume":"38","author":"E Tyrkko","year":"2016","unstructured":"Tyrkko E, Andersson M, Kronstrand R (2016) The toxicology of new psychoactive substances: synthetic cathinones and phenylethylamines. Ther Drug Monit 38:190\u2013216","journal-title":"Ther Drug Monit"},{"key":"5059_CR57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.forsciint.2014.03.013","volume":"243","author":"N Uchiyama","year":"2014","unstructured":"Uchiyama N, Matsuda S, Kawamura M et al (2014) Characterization of four new designer drugs, 5-chloro-NNEI, NNEI indazole analog, alpha-PHPP and alpha-POP, with 11 newly distributed designer drugs in illegal products. Forensic Sci Int 243:1\u201313","journal-title":"Forensic Sci Int"},{"key":"5059_CR58","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/978-1-4939-7231-9_4","volume":"1654","author":"B Webb","year":"2017","unstructured":"Webb B, Sali A (2017) Protein structure modeling with MODELLER. Methods Mol Biol 1654:39\u201354","journal-title":"Methods Mol Biol"},{"key":"5059_CR59","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.pbb.2006.05.022","volume":"84","author":"S Wee","year":"2006","unstructured":"Wee S, Woolverton WL (2006) Self-administration of mixtures of fenfluramine and amphetamine by rhesus monkeys. Pharmacol Biochem Behav 84:337\u2013343","journal-title":"Pharmacol Biochem Behav"},{"key":"5059_CR60","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1124\/jpet.104.080101","volume":"313","author":"S Wee","year":"2005","unstructured":"Wee S, Anderson KG, Baumann MH et al (2005) Relationship between the serotonergic activity and reinforcing effects of a series of amphetamine analogs. J Pharmacol Exp Ther 313:848\u2013854","journal-title":"J Pharmacol Exp Ther"},{"key":"5059_CR61","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1097\/FTD.0000000000000240","volume":"38","author":"J Welter-Luedeke","year":"2016","unstructured":"Welter-Luedeke J, Maurer HH (2016) New psychoactive substances: chemistry, pharmacology, metabolism, and detectability of amphetamine derivatives with modified ring systems. Ther Drug Monit 38:4\u201311","journal-title":"Ther Drug Monit"},{"key":"5059_CR62","doi-asserted-by":"publisher","first-page":"2689","DOI":"10.1016\/S0968-0896(00)00210-8","volume":"8","author":"H Yu","year":"2000","unstructured":"Yu H, Rothman RB, Dersch CM et al (2000) Uptake and release effects of diethylpropion and its metabolites with biogenic amine transporters. Bioorg Med Chem 8:2689\u20132692","journal-title":"Bioorg Med Chem"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-018-5059-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00213-018-5059-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-018-5059-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T23:40:47Z","timestamp":1775259647000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00213-018-5059-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,5]]},"references-count":62,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["5059"],"URL":"https:\/\/doi.org\/10.1007\/s00213-018-5059-5","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,5]]},"assertion":[{"value":"30 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}